HOME >> MEDICINE >> NEWS
GroPep licenses technology to TGR BioSciences

GroPep announced today it has licensed its Whey Growth Factor Extract (WGFE) technology to Australian biotechnology company, TGR BioSciences (TGR).

TGR has raised $3 million to fund further clinical development of WGFE as a treatment for oral mucositis, a debilitating side effect of cancer treatments.

GroPep will receive royalties of more than 10% on TGR's commercialisation of the technology.

Biopharmaceutical company GroPep Limited (ASX: GRO) today announced that it has licensed certain Whey Growth Factor Extract (WGFE) technology rights to TGR BioSciences Pty Ltd (TGR). This arrangement will also allow TGR to raise additional funds to finance further development of the technology.

Under two separate agreements, venture capitalist Nanyang Innovation Fund managed by Nanyang Ventures (Nanyang) will invest up to $3 million, TGR will start a clinical trial of WGFE for oral mucositis and GroPep will license the WGFE technology to TGR.

GroPep will receive royalties of more than 10% from TGR on commercialisation of the technology and TGR has taken over responsibility for five patent families developed by GroPep and the related costs. GroPep's shareholding in TGR is reduced from 20% to 12%.

Among the rights licensed to TGR is GroPep's oral mucositis product technology. Oral mucositis is an extremely painful side effect afflicting chemotherapy patients. GroPep and collaborators have previously generated significant preclinical and clinical data, including a successful Phase 1b trial conducted at the Peter MacCallum Cancer Centre in Melbourne, indicating the safety and potential for WGFE to treat this condition. TGR has committed to initiate further clinical development in the oral mucositis setting within the next year.

Mr Gregory Moss-Smith, Vice President of Commercial Operations at GroPep, said "Licensing the technology to TGR, combined with the capital injection from Nanyang, is an effective means of advancing
'"/>

Contact: Tony Mitchell
investorrelations@gropep.com.au
61-883-547-700
Research Australia
26-Jul-2005


Page: 1 2

Related medicine news :

1. GroPep awarded key patent for infertility treatment in Europe
2. GroPep starts Phase 1 infertility trial
3. GroPep completes final milestone of the path malaria vaccine initiative
4. GroPep to pursue promising asthma drug following preclinical study results
5. GroPep news: Key psoriasis patent granted in Japan and new asthma patent filed for GroPep drug
6. Doctors working overseas face having licenses removed
7. UW licenses innovated cardiovascular software to VPDiagnostics
8. The Wistar Institute licenses rubella vaccine seed stock to Microgen of Russia
9. MCW Research Foundation licenses invention for stroke treatment
10. Wireless technology shows promise in diagnosing pediatric intestinal disease
11. Speeding up CT scans with cellphone technology, ultrasound warning signal for breast cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/19/2019)... ... ... Residents in long-term-care nursing facilities were prescribed fewer medications when treated by staff ... of U.S. men and women led by the staff at the Los Angeles ... The quality assurance study examined the high number of prescriptions ordered for long-term nursing ...
(Date:4/19/2019)... ... April 19, 2019 , ... The Patient Advocacy Community of ... Health Network-CVPH, Plattsburgh, NY with the 2019 Ruth Ravich Patient Advocacy Award in ... fellow patient advocates. Doyle was honored with the award at The Beryl Institute’s ...
(Date:4/18/2019)... ... 2019 , ... Swiss Pet company PerAnimal launches a new unique ... between human and animal while improving the overall wellness of pet companions. , All ... of experience. They are made by hand from organic Swiss herbal condensate and Swiss ...
(Date:4/18/2019)... Calif. (PRWEB) , ... April 18, 2019 , ... ... upscale dental practice in Beverly Hills that offers a full menu of cosmetic ... cosmetic treatments and sought-after expertise in biomimetic dentistry, which relies on minimally-invasive techniques ...
(Date:4/18/2019)... ... April 18, 2019 , ... WHAT:, Patients today have ... Through the rise of online review sites and healthcare-related searches on the web, ... making important purchasing decisions online. In order to elevate a health system’s reputation ...
Breaking Medicine News(10 mins):
(Date:4/19/2019)... ... 18, 2019 , ... Janice F. Whaley has a vision. A vision to make organ ... Ms. Whaley has focused her entire career on the mission of all the organ ... donation for transplantation. , There is a sad reality for the individuals who wait for ...
(Date:4/18/2019)... ... , ... MedMen – a cannabis retailer credited with redefining the ... – has partnered with Buxton to identify its most valuable customers and guide site ... tools will allow MedMen to identify their best target markets and strategically plan where ...
(Date:4/18/2019)... (PRWEB) , ... April 18, 2019 , ... ... defining Key Results™, shaping Cultural Beliefs®, and solving Accountability Gaps, and that is ... in the Suntiva team as a service provider to the FDA. This ...
Breaking Medicine Technology:
Cached News: